Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Fu

Showing results (801-810 of 924) with videos related to

Pageof 93
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 1998
Chemotherapy immediately following autologous stem-cell transplantation in patients with advanced breast cancerZ Rahman, J Kavanagh, R Champlin, et al.
ESMO Open|August 6, 2025
Autoantibody profiling to predict response to the anti-PD-1 therapy, pembrolizumab, in rare tumorsM H Derbala, J Hajjar, B Stephen, et al.
BMC Cancer|October 18, 2015
Retreatment with anti-EGFR based therapies in metastatic colorectal cancer: impact of intervening time interval and prior anti-EGFR responseX Liu, G C George, A M Tsimberidou, et al.
Physical Review. E|May 22, 2019
In situ spacecraft observations of a structured electron diffusion region during magnetopause reconnectionGiulia Cozzani, A Retinò, F Califano, et al.
Zhonghua Yu Fang Yi Xue Za Zhi [Chinese Journal of Preventive Medicine]|March 19, 2026
[Association between physical activity and non-alcoholic fatty liver disease among adults aged 65 and above in longevity regions of China]Y Q Chen, Y D Wu, C Chen, et al.
ESMO Open|March 15, 2021
Safety and activity of vandetanib in combination with everolimus in patients with advanced solid tumors: a phase I studyT Cascone, R L Sacks, I M Subbiah, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 21, 2016
Multiplex KRASG12/G13 mutation testing of unamplified cell-free DNA from the plasma of patients with advanced cancers using droplet digital polymerase chain reactionF Janku, H J Huang, T Fujii, et al.
ESMO Open|September 3, 2021
PIK3CA mutations in plasma circulating tumor DNA predict survival and treatment outcomes in patients with advanced cancersE E Dumbrava, S G Call, H J Huang, et al.
Clinical Laboratory|October 19, 2019
Neutrophil-to-Lymphocyte Ratio Improves the Accuracy and Sensitivity of Pneumonia Severity Index in Predicting 30-Day Mortality of CAP PatientsHai F Zhang, Yan L Ge, Hong Y Wang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 17, 2024
Subcutaneous versus intravenous nivolumab for renal cell carcinomaL Albiges, M T Bourlon, M Chacón, et al.
Pageof 93

Showing results (801-810 of 924) with videos related to

Sort By:
Pageof 93
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 1998
Chemotherapy immediately following autologous stem-cell transplantation in patients with advanced breast cancerZ Rahman, J Kavanagh, R Champlin, et al.
ESMO Open|August 6, 2025
Autoantibody profiling to predict response to the anti-PD-1 therapy, pembrolizumab, in rare tumorsM H Derbala, J Hajjar, B Stephen, et al.
BMC Cancer|October 18, 2015
Retreatment with anti-EGFR based therapies in metastatic colorectal cancer: impact of intervening time interval and prior anti-EGFR responseX Liu, G C George, A M Tsimberidou, et al.
Physical Review. E|May 22, 2019
In situ spacecraft observations of a structured electron diffusion region during magnetopause reconnectionGiulia Cozzani, A Retinò, F Califano, et al.
Zhonghua Yu Fang Yi Xue Za Zhi [Chinese Journal of Preventive Medicine]|March 19, 2026
[Association between physical activity and non-alcoholic fatty liver disease among adults aged 65 and above in longevity regions of China]Y Q Chen, Y D Wu, C Chen, et al.
ESMO Open|March 15, 2021
Safety and activity of vandetanib in combination with everolimus in patients with advanced solid tumors: a phase I studyT Cascone, R L Sacks, I M Subbiah, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 21, 2016
Multiplex KRASG12/G13 mutation testing of unamplified cell-free DNA from the plasma of patients with advanced cancers using droplet digital polymerase chain reactionF Janku, H J Huang, T Fujii, et al.
ESMO Open|September 3, 2021
PIK3CA mutations in plasma circulating tumor DNA predict survival and treatment outcomes in patients with advanced cancersE E Dumbrava, S G Call, H J Huang, et al.
Clinical Laboratory|October 19, 2019
Neutrophil-to-Lymphocyte Ratio Improves the Accuracy and Sensitivity of Pneumonia Severity Index in Predicting 30-Day Mortality of CAP PatientsHai F Zhang, Yan L Ge, Hong Y Wang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 17, 2024
Subcutaneous versus intravenous nivolumab for renal cell carcinomaL Albiges, M T Bourlon, M Chacón, et al.
Pageof 93